Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use this medication.
Immune reconstitution syndrome: Vitekta may cause immune reconstitution syndrome, where signs and symptoms of inflammation from previous infections appear. These symptoms occur soon after starting anti-HIV medication and can vary. They are thought to occur as a result of the immune system improving and being able to fight infections that have been present without symptoms (such as pneumonia, herpes, or Tuberculosis). Report any new symptoms to your doctor immediately.
Liver function: Liver disease or reduced liver function may cause Vitekta to build up in the body, causing side effects. Elvitegravir should not be used in people with severe liver impairment. If you have liver problems, discuss with your doctor how Vitekta may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Vitekta, and whether any special monitoring is needed. Your doctor may want to test your liver function regularly with blood tests while you are taking Vitekta.
Resistance: The HIV virus appears to be able to change to make elvitegravir less effective, if this medication is not used appropriately. To maximize the effectiveness of elvitegravir, it must be taken as part of a group of HIV medications that also includes ritonavir.
Stopping the medication: If you stop taking Vitekta, your HIV infection could get worse. Take the medication exactly as prescribed by your doctor, and do not stop taking the medication without checking with your doctor first.
Pregnancy: Vitekta should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Vitekta, contact your doctor immediately.
Breast-feeding: It is not known if elvitegravir passes into breast milk. Women who have HIV infection are cautioned against breast-feeding because of the risk of passing HIV to a baby who does not have the infection.
Children: The safety and effectiveness of using Vitekta have not been established for children.
Seniors: Seniors may be at an increased risk of side effects of Vitekta.